ResearchRSSMay 15
Protein changes may help explain Spinraza response in SMA
Researchers studied how Spinraza, a medicine for spinal muscular atrophy (SMA), changes certain proteins in the fluid around the brain and spinal cord. They found that these protein changes happen when the medicine works, and some of these changes match up with patients getting stronger and moving better. This helps doctors understand why the medicine helps some patients.
WHY IT MATTERSUnderstanding which protein changes in cerebrospinal fluid predict Spinraza response could help doctors identify which SMA patients are most likely to benefit from treatment and potentially guide future treatment decisions.